Suxamethonium apnoea developed in a patient who was a homozygote for the atypical gene. Fifty-five members of the patient's family were investigated. Seven further homozygotes were found. Suxamethonium apnoea had been demonstrated previously in one of these. Thirty-two members of the family were heterozygotes.
The short action of suxamethonium is a result of its hydrolysis by plasma cholinesterase, a dose of 20-100 mg normally producing 3-4 min muscular paralysis. Soon after the introduction of suxamethonium, prolonged apnoea was reported by several anaesthetists (Bourne, Collier and Somers, 1952; Evans et al., 1952) . In patients with a genetically inherited abnormality of plasma cholinesterase, apnoea is prolonged considerably. This report presents a patient with suxamethonium "apnoea" and details the results of the subsequent investigations of the patient's family.
METHODS
The serum cholinesterase concentrations were determined by the micromanometric method of Ammon (1933) . One unit of pseudocholinesterase enzyme activity is defined as that which hydrolyses 1 micromole of acetylcholine per minute per ml of serum at 37 °C.
The dibucaine numbers were determined by the method of Kalow and Genest (1957) , the fluoride numbers by the method of Harris and Whittaker (1961) and the butanol numbers by the method of Whittaker (1968) .
CASE REPORT
On September 11, 1974, a fit 38-year-old female patient (II 6 ,  
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Homozygote for the atypical gene After surgery the patient said that one of her sisters (II 8 , table I) had experienced a similar episode under anaesthesia on February 2, 1972, when she had undergone tubal ligation in the same hospital. Our hospital records revealed that the sister's dibucaine number was 17.5. Thus she was a homozygote for the atypical gene. Unfortunately, no further investigations of the family had been carried out at that time.
Following this case (II 6 , table I), full family investigations were undertaken. The genetic abnormality was explained to each member of the family and they were asked to attend for a blood test.
The results of the enzyme assays and inhibition studies on four generations of the family are shown in table I. A family tree showing the genetic type is shown in figure 1 .
The parents of the two sisters mentioned above were heterozygotes for the normal and atypical gene and of their 14 children, six were homozygotes for the atypical gene, four were heterozygotes for the normal and atypical gene and four were normal homozygotes.
The third generation produced two homozygotes for the atypical gene and 24 heterozygotes for the m i j: normal and atypical gene. In the fourth generation, so far, three heterozygotes have been produced. It is of interest that, in the case of the second son, one of the children by his first wife was a heterozygote and two of the children by his second wife were homozygotes for the atypical gene. Examination of this second wife revealed that she too was a heterozygote for the normal and atypical genes.
DISCUSSION
This investigation is unique in that the whole of a large family has been traced and tested. In many of the Suffolk villages intermarriage has occurred, and this probably accounts for the fact that, in one family, there are two occasions when two heterozygotes have married and produced several homozygote children.
In 1967 the importance of investigating families of affected patients was emphasized (Editorial, 1967) and, in 1968, suggestions were made that these investigations should be carried out on a national basis (Whittaker and Vickers, 1968) . The value of screening the relatives of patients with cholinesterase variants has been shown in a Regional Study in S.E. Scotland (Bauld et al., 1974) . The present investigation of a family supports this study. If this family had been screened in 1972 when the patient (II 8 , table I) suffered prolonged apnoea, then the difficulty with the later patient (II 6 , table I) could have been avoided.
The likelihood of prolonged apnoea occurring among heterozygotes for the normal and atypical gene is of great interest to anaesthetists. Of the 32 heterozygotes in this family only eight had received general anaesthetics. The majority of these heterozygotes appeared in the third and fourth generations and 53% of all the heterozygotes are under the age of 15 years. Only one of these patients (II 4 , table I) has received an anaesthetic in which suxamethonium was administered, and he did not react abnormally.
It has been suggested that investigations of this kind are unnecessary, time consuming and upsetting to the patient concerned. It has been our experience in Ipswich that all patients realize that it is in their best interest, and all have been extremely co-operative. Family screening is time consuming, but the avoidance of a 1-2 h delay in an operating list and the avoidance of an unnecessarily long anaesthetic for the patient, more than compensate for this.
It is now the policy of the Anaesthetic Department in this hospital to investigate, as far as possible, all members of the family when an affected patient is found. Cards are then issued to all patients affected stating their hypersensitivity to suxamethonium, the dibucaine number and the genotype. In addition a register is kept, in the Anaesthetic Department, of all patients hypersensitive to suxamethonium.
Another "affected" member of this family has received a general anaesthetic in this hospital, subsequent to this investigation. Because of her investigation as part of this family and her presentation of her suxamethonium hypersensitivity card on her admission, it was possible to avoid the administration of suxamethonium. 
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